Display options
Share it on

Front Microbiol. 2015 Mar 05;6:140. doi: 10.3389/fmicb.2015.00140. eCollection 2015.

An overview of the characteristics of the novel avian influenza A H7N9 virus in humans.

Frontiers in microbiology

Kei-Xian Tan, Sabrina A Jacob, Kok-Gan Chan, Learn-Han Lee

Affiliations

  1. Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia Bandar Sunway, Malaysia.
  2. School of Pharmacy, Monash University Malaysia Bandar Sunway, Malaysia.
  3. Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, University of Malaya Kuala Lumpur, Malaysia.

PMID: 25798131 PMCID: PMC4350415 DOI: 10.3389/fmicb.2015.00140

Abstract

The novel avian influenza A H7N9 virus which caused the first human infection in Shanghai, China; was reported on the 31st of March 2013 before spreading rapidly to other Chinese provinces and municipal cities. This is the first time the low pathogenic avian influenza A virus has caused human infections and deaths; with cases of severe respiratory disease with pneumonia being reported. There were 440 confirmed cases with 122 fatalities by 16 May 2014; with a fatality risk of ∼28%. The median age of patients was 61 years with a male-to-female ratio of 2.4:1. The main source of infection was identified as exposure to poultry and there is so far no definitive evidence of sustained person-to-person transmission. The neuraminidase inhibitors, namely oseltamivir, zanamivir, and peramivir; have shown good efficacy in the management of the novel H7N9 virus. Treatment is recommended for all hospitalized patients, and for confirmed and probable outpatient cases; and should ideally be initiated within 48 h of the onset of illness for the best outcome. Phylogenetic analysis found that the novel H7N9 virus is avian in origin and evolved from multiple reassortments of at least four origins. Indeed the novel H7N9 virus acquired human adaptation via mutations in its eight RNA gene segments. Enhanced surveillance and effective global control are essential to prevent pandemic outbreaks of the novel H7N9 virus.

Keywords: H7N9; avian influenza A; characteristics; novel; virus

References

  1. J Infect Dis. 1999 Aug;180(2):254-61 - PubMed
  2. Cancer. 2012 Sep 15;118(18):4627-33 - PubMed
  3. Clin Infect Dis. 2010 Oct 15;51(8):887-94 - PubMed
  4. Lancet. 2013 May 11;381(9878):1621 - PubMed
  5. Biosci Trends. 2013 Apr;7(2):109-12 - PubMed
  6. Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1:50-7 - PubMed
  7. Virus Res. 2014 Jan 22;179:119-24 - PubMed
  8. Emerg Infect Dis. 2013 Aug;19(8):1289-92 - PubMed
  9. N Engl J Med. 1997 Sep 25;337(13):874-80 - PubMed
  10. Lancet. 2013 Jul 13;382(9887):129-37 - PubMed
  11. N Engl J Med. 2009 Nov 12;361(20):1935-44 - PubMed
  12. J Virol. 1998 Mar;72(3):2456-62 - PubMed
  13. Am J Pathol. 2013 Oct;183(4):1137-43 - PubMed
  14. Euro Surveill. 2013 Apr 11;18(15):20453 - PubMed
  15. JAMA. 2000 Feb 23;283(8):1016-24 - PubMed
  16. EMBO J. 1985 Nov;4(11):3021-4 - PubMed
  17. Lancet. 2013 Jun 29;381(9885):2273-9 - PubMed
  18. J Virol. 2010 Jul;84(13):6825-33 - PubMed
  19. N Engl J Med. 2013 May 16;368(20):1888-97 - PubMed
  20. PLoS Pathog. 2009 Dec;5(12):e1000709 - PubMed
  21. J Virol. 2008 Feb;82(3):1146-54 - PubMed
  22. Clin Infect Dis. 2011 Feb 15;52(4):457-65 - PubMed
  23. BMJ. 2013 Aug 06;347:f4752 - PubMed
  24. BMC Med. 2013 Oct 02;11:214 - PubMed
  25. J Gen Virol. 2012 Jun;93(Pt 6):1278-87 - PubMed
  26. J Immunol. 2009 Sep 1;183(5):3294-301 - PubMed
  27. BMJ. 2010 Sep 28;341:c4779 - PubMed
  28. JAMA. 1999 Oct 6;282(13):1240-6 - PubMed
  29. Avian Dis. 2012 Dec;56(4 Suppl):818-28 - PubMed
  30. Virus Res. 2012 May;165(2):126-33 - PubMed
  31. Clin Infect Dis. 2013 Aug;57(4):622-4 - PubMed
  32. N Engl J Med. 2014 Feb 6;370(6):520-32 - PubMed
  33. Pediatr Infect Dis J. 2001 Feb;20(2):127-33 - PubMed
  34. J Virol. 2012 Apr;86(8):4370-9 - PubMed
  35. Lancet. 2013 Jun 15;381(9883):2134 - PubMed
  36. J Antimicrob Chemother. 2011 May;66(5):1150-5 - PubMed
  37. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4381-6 - PubMed
  38. Lancet Infect Dis. 2013 Sep;13(9):809-21 - PubMed
  39. N Engl J Med. 2013 Jun 13;368(24):2277-85 - PubMed
  40. Influenza Other Respir Viruses. 2013 Jan;7 Suppl 1:25-36 - PubMed
  41. J Virol. 1997 May;71(5):3385-90 - PubMed
  42. Emerg Infect Dis. 2013 Dec;19(12):2041-3 - PubMed
  43. Western Pac Surveill Response J. 2013 May 21;4(2):4-7 - PubMed
  44. Lancet. 2000 May 27;355(9218):1845-50 - PubMed
  45. Science. 2012 Jun 22;336(6088):1534-41 - PubMed
  46. Lancet. 2013 May 25;381(9880):1815-6 - PubMed
  47. J Clin Invest. 1998 Feb 1;101(3):643-9 - PubMed
  48. Pediatr Infect Dis J. 2000 May;19(5):410-7 - PubMed
  49. Virology. 1994 Nov 15;205(1):17-23 - PubMed
  50. Antimicrob Agents Chemother. 2003 Jul;47(7):2264-72 - PubMed
  51. Clin Infect Dis. 2014 Jan;58(2):242-6 - PubMed
  52. Cell. 1992 May 1;69(3):517-28 - PubMed
  53. Clin Microbiol Infect. 2014 Aug;20(8):O493-500 - PubMed
  54. Avian Dis. 2012 Dec;56(4 Suppl):845-8 - PubMed
  55. PLoS Pathog. 2012;8(11):e1002932 - PubMed
  56. Cell Res. 2013 Dec;23(12):1347-55 - PubMed
  57. Trends Microbiol. 2014 Nov;22(11):623-31 - PubMed
  58. Virology. 2007 Jun 5;362(2):271-82 - PubMed
  59. PLoS One. 2013 Oct 15;8(10 ):e77651 - PubMed
  60. JAMA. 2010 Apr 21;303(15):1517-25 - PubMed
  61. J Antimicrob Chemother. 2011 May;66(5):959-63 - PubMed
  62. J Virol. 2006 Aug;80(16):7976-83 - PubMed
  63. Nature. 2013 Jul 25;499(7459):496-9 - PubMed
  64. J Virol. 1999 Feb;73(2):1146-55 - PubMed
  65. Arch Intern Med. 2001 Jan 22;161(2):212-7 - PubMed
  66. Clin Infect Dis. 2011 Aug 1;53(3):277-9 - PubMed
  67. J Infect Dis. 2013 Feb 15;207(4):553-63 - PubMed
  68. Lancet. 2013 Jul 13;382(9887):138-45 - PubMed
  69. Avian Dis. 1996 Apr-Jun;40(2):425-37 - PubMed
  70. Science. 2001 Sep 7;293(5536):1840-2 - PubMed
  71. Euro Surveill. 2013 Nov 21;18(47):null - PubMed
  72. Science. 2013 Oct 11;342(6155):243-7 - PubMed
  73. Euro Surveill. 2013 Apr 25;18(17 ):20465 - PubMed
  74. Pediatr Infect Dis J. 2005 Oct;24(10):931-2 - PubMed
  75. Nature. 2013 Sep 26;501(7468):560-3 - PubMed
  76. Annu Rev Biochem. 1983;52:467-506 - PubMed
  77. J Virol. 2005 Sep;79(18):12058-64 - PubMed
  78. J Infect. 2013 Dec;67(6):595-605 - PubMed
  79. J Virol. 2010 Jul;84(13):6570-7 - PubMed
  80. J Gen Virol. 2013 Nov;94(Pt 11):2417-23 - PubMed
  81. MBio. 2013 Oct 08;4(5):e00601-13 - PubMed
  82. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11181-6 - PubMed
  83. Sci Rep. 2013 Oct 28;3:3058 - PubMed
  84. Lancet. 2013 Jun 1;381(9881):1916-25 - PubMed
  85. Virology. 2009 Feb 5;384(1):28-32 - PubMed
  86. Science. 2013 Jul 12;341(6142):183-6 - PubMed
  87. N Engl J Med. 2010 Jun 10;362(23):2175-84 - PubMed
  88. Lancet. 2013 Jun 1;381(9881):1926-32 - PubMed
  89. Emerg Infect Dis. 2013 Jul;19(7):1179-81 - PubMed
  90. MBio. 2013 Jul 16;4(4):null - PubMed
  91. Nat Commun. 2013;4:2854 - PubMed
  92. Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8091-6 - PubMed
  93. Ann Intern Med. 2012 Apr 3;156(7):512-24 - PubMed
  94. Cell. 2013 Jun 20;153(7):1486-93 - PubMed
  95. J Antimicrob Chemother. 2011 May;66(5):1140-9 - PubMed
  96. Virology. 2003 Jan 5;305(1):192-200 - PubMed
  97. Nature. 2013 Sep 26;501(7468):551-5 - PubMed
  98. Clin Infect Dis. 2012 Nov;55(9):1198-204 - PubMed

Publication Types